Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: HELIX BIOSTRUCTURES LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-09-03 to 2025-03-02
Current total value of award: $24500
Description: CRYSTALLIZATION AND STRUCTURE SOLUTION SERVICES FOR BILIVERDIN REDUCTASE A FOR THE NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES